Trial Profile
Effect of ALlopurinol in Addition to Hypothermia for Hypoxic-ischemic Brain Injury on Neurocognitive Outcome - a Blinded Randomized Placebo-controlled Parallel Group Multicenter Trial for Superiority (Phase III)
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 09 Feb 2024
Price :
$35
*
At a glance
- Drugs Allopurinol (Primary) ; Mannitol
- Indications Brain hypoxia-ischaemia
- Focus Pharmacodynamics
- Acronyms ALBINO
- 24 Jan 2024 Detailed statistical analysis plan for ALBINO, published in the Trials
- 07 Jul 2023 Planned number of patients changed from 846 to 760.
- 07 Jul 2023 Planned End Date changed from 1 Jun 2025 to 31 Jan 2026.